Back to Agenda
Session 4, Track B: Rebuilding Trust and Awareness in Clinical Trials
Session Chair(s)
Marie-France Goyer, MSc
Senior Director, Clinical Operations
Abcellera, Canada
Stephanie Anderson, MS
Associate Director, Regulatory Affairs
Intrinsik Corp., Canada
This session explores the shifting landscape of public engagement with clinical trials. It begins with strategies to rebuild trust and reshape the narrative surrounding clinical research. Attendees will gain insights from National trends on public perception and learn about patient centric initiatives that promote transparency and the importance of sharing clinical trial results.
- Rebuilding Public Trust: Changing the Narrative Around Clinical Trials
Fraser Gibson, Advantage Clinical - Rebuilding Public Trust: Changing the Narrative Around Clinical Trials
Alison Orth, Michal Smith Health Research BC
Learning Objective :
At the conclusion of this session, participants should be able to:
- Summarize strategies to rebuild trust and increase public engagement in clinical trials
- Identify misconceptions and past ethical failures that drive public distrust, amplified by media
- Recognize strategies like transparency, education and patient-centricity can rebuild trust
Speaker(s)
Rebuilding Public Trust: Changing the Narrative Around Clinical Trials
Fraser Gibson, MBA
Advantage Clinical, Canada
Founder
Rebuilding Public Trust: Changing the Narrative Around Clinical Trials
Alison Orth
Clinical Trials British Columbia, Canada
Director
Have an account?